# TMDX — AI stock forecast & analysis

> AI-generated analysis by K3vl4r — 2026-06-30. Informational only, not financial advice.

**Recommendation:** ACCUMULATE

**Scores (0–100):** Overall 6 · Fundamentals 7.5 · Technicals 4 · Growth 8 · Risk 6.5

## Summary

TMDX presents a compelling fundamental story anchored by its proprietary OCS platform and strong historical growth (30% TTM revenue growth), but the stock is currently battling significant negative momentum and valuation concerns relative to its highs. The technical picture shows deep retracement, suggesting caution despite positive analyst commentary on the core technology.

## Price targets (12-month horizon)

- Bear: $60.10
- Base: $95.00
- Bull: $130.00

## News context

The news flow highlights TMDX's core strength—the OCS platform for organ preservation—and its strong growth profile. Analyst coverage remains positive on the technology (e.g., Stifel raising PT to $80), and recent articles frame it as an 'Affordable Growth Stock.' The primary noise comes from insider selling ($722k sale) and general market volatility, which has pressured the stock price despite solid fundamentals.

## About
- Methodology: https://app.k3vl4r.com/methodology
- Full report: https://app.k3vl4r.com/r/tmdx-ai-stock-forecast-03d34c94c9ff6ef18ce1162688be6c16
- AI-generated; model outputs can be wrong. Not financial advice.